Workflow
脑机接口加速从实验室迈向市场 “人机共生”即将照进现实
Zheng Quan Ri Bao·2025-06-08 17:08

Core Insights - The brain-computer interface (BCI) sector is experiencing unprecedented growth driven by technology and capital, offering hope for patients with paralysis and signaling the potential for a new industrial revolution [1] - The first batch of flexible high-throughput semi-invasive wireless fully implanted BCI systems has been successfully implanted, showing over 98% efficiency in neural signal collection [1] - The market is witnessing significant capital interest, exemplified by Neuralink's successful $650 million Series E funding round, raising its valuation to $9 billion [8] Industry Development - Clinical validation is identified as a major bottleneck in the BCI technology's progress, with the need for solid clinical efficacy evidence before widespread commercialization [3][4] - Various BCI companies are actively conducting clinical trials, with a focus on enhancing system integration and expanding large-scale clinical validation efforts [3] - Cities like Beijing and Shanghai are implementing plans to accelerate the construction of clinical trial platforms to facilitate the conversion of technological achievements into practical applications [3] Application Scenarios - Semi-invasive and invasive BCI technologies are primarily focused on the medical field, providing potential recovery solutions for patients with paralysis, ALS, blindness, and deafness [5] - Non-invasive BCI technologies are gradually entering commercial use in medical rehabilitation, while also expanding into education, safety, and entertainment sectors [5][6] Capital Dynamics - The BCI industry is attracting significant capital investment due to its potential to revolutionize memory storage and human-machine interaction [8] - In addition to Neuralink, domestic companies are also securing substantial funding, with Shanghai Jieti Medical Technology completing a Series B funding round of 350 million yuan [8] - A-share listed companies are adopting dual strategies in invasive and non-invasive BCI technologies, with various firms actively developing related products and technologies [9] Industry Collaboration - The BCI industry is in a growth phase, with talent being a critical asset, necessitating collaboration across disciplines such as biomedicine, psychology, and computer science [9] - There is a call for enhanced communication and cooperation among industry players to build a complete and efficient industrial ecosystem, fostering the growth of the BCI sector [9]